Price (delayed)
$130.51
Market cap
$49.75B
P/E Ratio
10.64
Dividend/share
N/A
EPS
$12.27
Enterprise value
$47.24B
Moderna is an American, Cambridge, Massachusetts-based biotechnology company focused on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA . The Moderna technology platform is to insert
There are no recent dividends present for MRNA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.